Sarcopenia and Physical Function in Middle-Aged and Older Stroke Survivors

Overview

Journal Arch Phys Med Rehabil

Specialty Rehabilitation Medicine

Date 2016 Aug 18

PMID 27530769

Citations 38

Authors

Alice S Ryan

Frederick M Ivey

Monica C Serra

Joseph Hartstein

Charlene E Hafer-Macko

Affiliations

Soon will be listed here.

Abstract

Objectives: To determine the prevalence of sarcopenia in stroke survivors using different methodologies, and compare a subset of the stroke group to age-, sex-, and body mass index (BMI)-matched nonstroke control counterparts.

Design: Cohort study.

Setting: A Veterans Affairs medical center and a university hospital.

Participants: Mild to moderately disabled participants >6 months after onset of stroke aged 40 to 84 years (N=190, 61% men, 57% African American; mean BMI ± SEM, 29±1kg/m).

Interventions: Not applicable.

Main Outcome Measures: Dual-energy x-ray absorptiometry scans to assess appendicular lean mass (ALM). Rates of sarcopenia were determined using 4 established methods: (1) ALM/height (ALM/ht); (2) European Working Group on Sarcopenia in Older Persons; (3) International Working Group on Sarcopenia; and (4) ALM/BMI.

Results: Sarcopenia prevalence in our stroke cohort ranged between 14% and 18%. The stroke survivor subset (n=38) matched one-for-one with control counterparts for race, sex, age ±4 years and BMI ±2.5kg/m had higher prevalence rates compared with their nonstroke counterparts (13.2% vs 5.3%, P<.0001). ALM/ht was related to 6-minute walking speed (r=.28, P<.01) and peak oxygen consumption (L/min: r=.58, P<.0001) for the stroke group.

Conclusions: Stroke survivors show an elevated prevalence of sarcopenia when considering age, sex, and race compared with nonstroke individuals.

Citing Articles

Clinical Significance of Sarcopenia Defined by the Cross-Sectional Area of the Masseter Muscle in Cerebrovascular Events: A Retrospective Cohort Study.

Segmen F, Aydemir S, Kayan T, Bicer F, Dogu C, Aktekin E Medicina (Kaunas). 2025; 61(2).

PMID: 40005385 PMC: 11857208. DOI: 10.3390/medicina61020268.

Personalised screening tool for early detection of sarcopenia in stroke patients: a machine learning-based comparative study.

Yan H, Li J, Li Y, Xian L, Tang H, Zhao X Aging Clin Exp Res. 2025; 37(1):40.

PMID: 39979762 PMC: 11842499. DOI: 10.1007/s40520-025-02945-5.

Risk factors of stroke-related sarcopenia: a systematic review and meta-analysis.

Yan H, Li J, Xian L, Li Y, Li S, Wen Q Front Aging. 2025; 6:1452708.

PMID: 39967995 PMC: 11833335. DOI: 10.3389/fragi.2025.1452708.

Prevalence and risk factors of sarcopenia in patients with stroke: a systematic review and meta-analysis.

He X, Shen X, Yang T, Ma G, Nan J, Feng J Neurosurg Rev. 2024; 48(1):6.

PMID: 39729202 DOI: 10.1007/s10143-024-03143-z.

Insulin resistance and sarcopenia: a prognostic longitudinal link to stroke risk in middle-aged and elderly Chinese population.

Guo C, He L, Tu Y, Xu C, Liao C, Lai H BMC Public Health. 2024; 24(1):2757.

PMID: 39385146 PMC: 11465621. DOI: 10.1186/s12889-024-20214-4.

References

Addison O, Drummond M, LaStayo P, Dibble L, Wende A, McClain D . Intramuscular fat and inflammation differ in older adults: the impact of frailty and inactivity. J Nutr Health Aging. 2014; 18(5):532-8. PMC: 6639009. DOI: 10.1007/s12603-014-0019-1. View

Janssen I, Shepard D, Katzmarzyk P, Roubenoff R . The healthcare costs of sarcopenia in the United States. J Am Geriatr Soc. 2003; 52(1):80-5. DOI: 10.1111/j.1532-5415.2004.52014.x. View

Morley J, Abbatecola A, Argiles J, Baracos V, Bauer J, Bhasin S . Sarcopenia with limited mobility: an international consensus. J Am Med Dir Assoc. 2011; 12(6):403-9. PMC: 5100674. DOI: 10.1016/j.jamda.2011.04.014. View

Cruz-Jentoft A, Landi F, Topinkova E, Michel J . Understanding sarcopenia as a geriatric syndrome. Curr Opin Clin Nutr Metab Care. 2009; 13(1):1-7. DOI: 10.1097/MCO.0b013e328333c1c1. View

Ryan A, Dobrovolny C, Silver K, Smith G, Macko R . Cardiovascular fitness after stroke: Role of muscle mass and gait deficit severity. J Stroke Cerebrovasc Dis. 2013; 9(4):185-91. DOI: 10.1053/jscd.2000.7237. View

Ryan A, Ivey F, Prior S, Li G, Hafer-Macko C . Skeletal muscle hypertrophy and muscle myostatin reduction after resistive training in stroke survivors. Stroke. 2010; 42(2):416-20. PMC: 3026882. DOI: 10.1161/STROKEAHA.110.602441. View

Evans W, Campbell W . Sarcopenia and age-related changes in body composition and functional capacity. J Nutr. 1993; 123(2 Suppl):465-8. DOI: 10.1093/jn/123.suppl_2.465. View

Cruz-Jentoft A, Baeyens J, Bauer J, Boirie Y, Cederholm T, Landi F . Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010; 39(4):412-23. PMC: 2886201. DOI: 10.1093/ageing/afq034. View

Landi F, Liperoti R, Fusco D, Mastropaolo S, Quattrociocchi D, Proia A . Prevalence and risk factors of sarcopenia among nursing home older residents. J Gerontol A Biol Sci Med Sci. 2011; 67(1):48-55. DOI: 10.1093/gerona/glr035. View

10.

Patel H, Syddall H, Jameson K, Robinson S, Denison H, Roberts H . Prevalence of sarcopenia in community-dwelling older people in the UK using the European Working Group on Sarcopenia in Older People (EWGSOP) definition: findings from the Hertfordshire Cohort Study (HCS). Age Ageing. 2013; 42(3):378-84. PMC: 3633365. DOI: 10.1093/ageing/afs197. View

11.

Cruz-Jentoft A, Landi F, Schneider S, Zuniga C, Arai H, Boirie Y . Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing. 2014; 43(6):748-59. PMC: 4204661. DOI: 10.1093/ageing/afu115. View

12.

Bijlsma A, Meskers C, Ling C, Narici M, Kurrle S, Cameron I . Defining sarcopenia: the impact of different diagnostic criteria on the prevalence of sarcopenia in a large middle aged cohort. Age (Dordr). 2012; 35(3):871-81. PMC: 3636407. DOI: 10.1007/s11357-012-9384-z. View

13.

Folstein M, Folstein S, McHugh P . "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12(3):189-98. DOI: 10.1016/0022-3956(75)90026-6. View

14.

Baumgartner R, Koehler K, Gallagher D, Romero L, Heymsfield S, Ross R . Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 1998; 147(8):755-63. DOI: 10.1093/oxfordjournals.aje.a009520. View

15.

Gianoudis J, Bailey C, Daly R . Associations between sedentary behaviour and body composition, muscle function and sarcopenia in community-dwelling older adults. Osteoporos Int. 2014; 26(2):571-9. DOI: 10.1007/s00198-014-2895-y. View

16.

Ovbiagele B, Goldstein L, Higashida R, Howard V, Johnston S, Khavjou O . Forecasting the future of stroke in the United States: a policy statement from the American Heart Association and American Stroke Association. Stroke. 2013; 44(8):2361-75. DOI: 10.1161/STR.0b013e31829734f2. View

17.

Patterson S, Forrester L, Rodgers M, Ryan A, Ivey F, Sorkin J . Determinants of walking function after stroke: differences by deficit severity. Arch Phys Med Rehabil. 2007; 88(1):115-9. DOI: 10.1016/j.apmr.2006.10.025. View

18.

Volpato S, Bianchi L, Cherubini A, Landi F, Maggio M, Savino E . Prevalence and clinical correlates of sarcopenia in community-dwelling older people: application of the EWGSOP definition and diagnostic algorithm. J Gerontol A Biol Sci Med Sci. 2013; 69(4):438-46. PMC: 3968828. DOI: 10.1093/gerona/glt149. View

19.

Ryan A, Buscemi A, Forrester L, Hafer-Macko C, Ivey F . Atrophy and intramuscular fat in specific muscles of the thigh: associated weakness and hyperinsulinemia in stroke survivors. Neurorehabil Neural Repair. 2011; 25(9):865-72. PMC: 3546168. DOI: 10.1177/1545968311408920. View

20.

Beaudart C, Reginster J, Slomian J, Buckinx F, Locquet M, Bruyere O . Prevalence of sarcopenia: the impact of different diagnostic cut-off limits. J Musculoskelet Neuronal Interact. 2014; 14(4):425-31. View